Consumer
The partnership has been terminated less than two months after launch as Novo Nordisk alleges Hims & Hers is illegally selling copycat drugs and using deceptive marketing practices.
Julien Payen, cofounder and CEO of Lattice Medical, describes the company's 3D-printed, resorbable breast implant that uses a patient's own fat to regenerate natural breast tissue after a mastectomy.
Julien Payen, cofounder and CEO of Lattice Medical, discusses the company’s 3D-printed breast implant that supports women recovering from mastectomy using a scaffold that gradually dissolves as the patient’s own tissue regenerates.
The vision-restoring device will be implanted in humans within six to 12 months, following a successful monkey implantation that has remained active for three years, Musk said.
HIMSS25
Dr. Sarah Hoffe, interim GI oncology chair at Moffitt Cancer Center, says telemedicine platforms and other technologies help ease nurse burnout, boost patient adherence and enable focused, personalized patient connections.
The partnership will allow Oura Ring wearers to share their biometric data with the virtual women's health company's care teams.
Anil Soni, CEO of the WHO Foundation, discusses a $3.6 million fundraising initiative, enhanced by a dollar-for-dollar match, to protect the Global Measles and Rubella Laboratory Network, working to control and eliminate both diseases.
HIMSS25
Rahul Mahadevan, founder and CEO of The WiTT Group, discusses the company's platform, which empowers patients to reach out for their non-clinical needs and gives health systems visibility into patients' biggest challenges.
Millie founder and CEO Anu Sharma discusses reasons why one-third of the U.S. is considered a "maternity care desert" and what can be done.
The partners will develop and clinically validate an AI tool that integrates into EHRs to accelerate the diagnosis of hypophosphatasia, a rare genetic bone disorder.